SelectScience
Join Free
CLINICAL24 2026
NewsClinical Diagnostics

Aiforia collaborates with PathAI to broaden access to AI-driven diagnostics

The agreement extends the reach of Aiforia's AI models to a broader base of laboratories across both Europe and the United States

12 Oct 2026
Aiforia collaborates with PathAI to broaden access to AI-driven diagnostics

Aiforia has announced a commercial agreement with PathAI, a member of the Roche Group and the developer of AISight® Dx Image Management System (IMS)*. In this collaboration, Aiforia's AI solutions will be made available to laboratories through the AISight Marketplace.

The agreement pairs Aiforia's deep learning technology and position as a provider of CE-IVD marked AI solutions for digital pathology in Europe with PathAI's strong installed base and presence in the United States, extending the reach of Aiforia's AI models to a broader base of laboratories across both regions.

“This agreement with PathAI is an important step in expanding access to Aiforia's AI solutions. By making our models available through AISight Dx, we can reach laboratories and pathologists who are already working within PathAI's platform and strengthen our presence especially in the U.S. market,” said Jukka Tapaninen, CEO of Aiforia.

"Our goal with AISight Dx is to give pathologists everything they need in one place," added Nick Brown, Chief Growth Officer, PathAI. "With Aiforia's AI solutions embedded directly into case review workflows, alongside our expanding algorithm catalog and seamless connectivity to lab and hospital IT systems through AISight Link, laboratories get a single, curated ecosystem spanning biomarker quantification, tissue classification, and diagnostic decision support, all contracted, billed, and supported through PathAI."

* AISight® Dx is CE-IVD-marked for primary diagnosis in the EEA, CH, and UK.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Tags

Artificial Intelligence / Machine LearningArtificial intelligence (AI) and machine learning (ML) are transformative technologies used to analyze complex data, identify patterns, and make data-driven predictions across diverse scientific fields. Automate the analysis of large or complex data sets using AI algorithms and leverage machine learning models to improve diagnostics, accelerate drug discovery, and refine experimental design. Discover the best AI/ML software, platforms, and analytical tools in our peer-reviewed product directory: compare features, read customer reviews, and request pricing directly from manufacturers.Digital PathologyDigital pathology involves the use of digital imaging and computational tools to analyze pathology slides. It is transforming diagnostics, research, and education by offering enhanced image storage and analysis. Explore digital pathology solutions in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.

Frequently asked questions

Show frequently asked questions

How will the Aiforia and PathAI commercial agreement expand access to AI-powered digital pathology?

Aiforia’s AI solutions will be offered to laboratories through the AISight Marketplace. The agreement combines Aiforia’s deep learning technology and European presence with PathAI’s installed base in the United States, extending Aiforia’s AI models to more laboratories across both regions.

What digital pathology capabilities will Aiforia add to PathAI’s AISight Dx platform?

Aiforia’s AI solutions will be embedded directly into AISight Dx® case review workflows. Alongside PathAI’s algorithm catalog and AISight Link connectivity to laboratory and hospital IT systems, the platform will support biomarker quantification, tissue classification, and diagnostic decision support in one curated ecosystem.

Is PathAI’s AISight Dx Image Management System CE-IVD marked for primary diagnosis?

Yes. AISight Dx is CE-IVD marked for primary diagnosis in the European Economic Area, Switzerland, and the United Kingdom.

Related articles